AORT.NYSEArtivion, INC

Form 4: Artivion Inc. Director Jeffrey H. Burbank Reports Acquisition of 6,289 Shares

Sentiment:

SEC Form 4 Filing


Director Jeffrey H. Burbank reports acquiring 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.

Summary

  • On May 30, 2024, Jeffrey H. Burbank, a director of Artivion Inc., acquired 6,289 shares of common stock.
  • The acquisition was part of an RSA (Restricted Stock Award) grant.
  • The RSA grant vests on May 30, 2025, according to the terms of the Equity and Cash Incentive Plan.
  • Following the transaction, Burbank beneficially owns 47,471 shares of Artivion Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock transaction. The acquisition of shares by a director is generally viewed as a positive sign, but it's not a major event.

Positives

  • The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in the corporate world. It provides transparency into the actions of company directors and their holdings in the company.

Stakeholder Impact

  • The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
05/30/2024Date of transaction: Acquisition of 6,289 shares of common stock via RSA grant.
05/30/2025Vesting date of the RSA grant.
06/03/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.